Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sanofi SA (NYSE:SNY)

40.02
Delayed Data
As of Dec 02
 +0.30 / +0.76%
Today’s Change
36.81
Today|||52-Week Range
44.50
-6.17%
Year-to-Date
Novo Nordisk's Tresiba Shows Safe Cardiovascular Profile
Nov 30 / Zacks.com - Paid Partner Content
Amicus Tumbles on Lengthy Delay to U.S. Fabry Drug FDA Filing Plan
Nov 28 / TheStreet.com - Paid Partner Content
NVIDIA, Sotheby's Holdings, Celgene, Regeneron Pharmaceuticals and Sanofi highlighted...
Nov 30 / Zacks.com - Paid Partner Content
3 Biotechs That Don't Pay Dividends -- but Could
Nov 22 / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights: UnitedHealth, 21st Century Fox, Sanofi, MasterCard...
Nov 30 / Zacks.com - Paid Partner Content
Glaxo Files for COPD Drug; FluLaval Approved for Infants
Nov 22 / Zacks.com - Paid Partner Content
Warren Buffett's Only Dividend Stocks With 4%-Plus Yields
Nov 29 / GuruFocus News - Paid Partner Content
Sanofi (SNY) Soliqua Approved for Type 2 Diabetes in Adults
Nov 22 / Zacks.com - Paid Partner Content
Top Research Reports for 29th November, 2016
Nov 29 / Zacks.com - Paid Partner Content
Here's Why Immune Design Should Be in Your Portfolio Now
Nov 21 / Zacks.com - Paid Partner Content
Celgene vs. Regeneron: Which Stock is a Better Pick?
Nov 29 / Zacks.com - Paid Partner Content
Drug and biotech stocks soar on Trump victory
Nov 09 / CNNMoney.com
Actelion Shares Fall Sharply on Report it is Resisting $17 billion J&J Takeover
Nov 29 / TheStreet.com - Paid Partner Content